Form 8-K - Current report:
SEC Accession No. 0001437749-25-020652
Filing Date
2025-06-17
Accepted
2025-06-17 16:21:00
Documents
13
Period of Report
2025-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K allr20250617_8k.htm   iXBRL 8-K 38487
  Complete submission text file 0001437749-25-020652.txt   173298

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA allr-20250613.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20250613_def.xml EX-101.DEF 11804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20250613_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20250613_pre.xml EX-101.PRE 12019
15 EXTRACTED XBRL INSTANCE DOCUMENT allr20250617_8k_htm.xml XML 2947
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 251053578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)